Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Colorcon
Merck
Boehringer Ingelheim
Mallinckrodt

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for HUMULIN N

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for HUMULIN N (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $352,369,518
INSIDE ANOTHER STORE $130,766,172
[disabled in preview] $253,483,860
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 379,901
INSIDE ANOTHER STORE 557,693
[disabled in preview] 809,247
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $29,943,629
MEDICARE $427,293,091
[disabled in preview] $279,382,828
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for HUMULIN N
Drug Units Sold Trends for HUMULIN N

Annual Sales Revenues and Units Sold for HUMULIN N

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
HUMULIN N   Start Trial   Start Trial 2017
HUMULIN N   Start Trial   Start Trial 2016
HUMULIN N   Start Trial   Start Trial 2015
HUMULIN N   Start Trial   Start Trial 2014
HUMULIN N   Start Trial   Start Trial 2013
HUMULIN N   Start Trial   Start Trial 2012
HUMULIN N   Start Trial   Start Trial 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Colorcon
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.